Atezolizumab-induced myositis in a patient with small-cell lung cancer.
Elif SahinDevrim CabukFatma Tuncer KuruAyten YaziciPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
The literature contains only a few case reports about atezolizumab-induced myositis, highlighting the challenges in defining its clinical features and management. Prompt diagnosis and treatment are crucial to prevent severe complications, such as myocarditis or respiratory muscle paralysis.